These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
119 related items for PubMed ID: 2621414
1. Concentrations of cholestenoic acids in plasma from patients with liver disease. Axelson M, Mörk B, Aly A, Wisén O, Sjövall J. J Lipid Res; 1989 Dec; 30(12):1877-82. PubMed ID: 2621414 [Abstract] [Full Text] [Related]
2. Concentrations of cholestenoic acids in plasma from patients with reduced intestinal reabsorption of bile acids. Axelson M, Mörk B, Aly A, Walldius G, Sjövall J. J Lipid Res; 1989 Dec; 30(12):1883-7. PubMed ID: 2621415 [Abstract] [Full Text] [Related]
4. Potential bile acid precursors in plasma--possible indicators of biosynthetic pathways to cholic and chenodeoxycholic acids in man. Axelson M, Sjövall J. J Steroid Biochem; 1990 Aug 28; 36(6):631-40. PubMed ID: 2214780 [Abstract] [Full Text] [Related]
5. On the origin of the cholestenoic acids in human circulation. Meaney S, Babiker A, Lütjohann D, Diczfalusy U, Axelson M, Björkhem I. Steroids; 2003 Sep 28; 68(7-8):595-601. PubMed ID: 12957664 [Abstract] [Full Text] [Related]
6. Levels of 7 alpha-hydroxy-4-cholesten-3-one in plasma reflect rates of bile acid synthesis in man. Axelson M, Aly A, Sjövall J. FEBS Lett; 1988 Nov 07; 239(2):324-8. PubMed ID: 3181435 [Abstract] [Full Text] [Related]
7. Significance of plasma 7alpha-hydroxy-4-cholesten-3-one and 27-hydroxycholesterol concentrations as markers for hepatic bile acid synthesis in cholesterol-fed rabbits. Honda A, Yoshida T, Xu G, Matsuzaki Y, Fukushima S, Tanaka N, Doy M, Shefer S, Salen G. Metabolism; 2004 Jan 07; 53(1):42-8. PubMed ID: 14681840 [Abstract] [Full Text] [Related]
8. Bile acids and bile alcohols in a child with hepatic 3 beta-hydroxy-delta 5-C27-steroid dehydrogenase deficiency: effects of chenodeoxycholic acid treatment. Ichimiya H, Egestad B, Nazer H, Baginski ES, Clayton PT, Sjövall J. J Lipid Res; 1991 May 07; 32(5):829-41. PubMed ID: 2072042 [Abstract] [Full Text] [Related]
9. Identification of 7 alpha-hydroxy-3-oxo-4-cholestenoic acid in chronic subdural hematoma. Nagata K, Takakura K, Asano T, Seyama Y, Hirota H, Shigematsu N, Shima I, Kasama T, Shimizu T. Biochim Biophys Acta; 1992 Jun 22; 1126(2):229-36. PubMed ID: 1627627 [Abstract] [Full Text] [Related]
10. Analysis of plasma bile acid profiles in patients with liver diseases associated with cholestasis. Bremmelgaard A, Almé B. Scand J Gastroenterol; 1980 Jun 22; 15(5):593-600. PubMed ID: 7444367 [Abstract] [Full Text] [Related]
11. Quantification of individual serum bile acids in patients with liver diseases using high-performance liquid chromatography. Okuda H, Obata H, Nakanishi T, Hisamitsu T, Matsubara K, Watanabe H. Hepatogastroenterology; 1984 Aug 22; 31(4):168-71. PubMed ID: 6479837 [Abstract] [Full Text] [Related]
12. Serum bile acids in liver disease. Neale G, Lewis B, Weaver V, Panveliwalla D. Gut; 1971 Feb 22; 12(2):145-52. PubMed ID: 5548561 [Abstract] [Full Text] [Related]
13. Differential interaction of bile acids from patients with inborn errors of bile acid synthesis with hepatocellular bile acid transporters. Stieger B, Zhang J, O'Neill B, Sjövall J, Meier PJ. Eur J Biochem; 1997 Feb 15; 244(1):39-44. PubMed ID: 9063443 [Abstract] [Full Text] [Related]
14. Concurrent occurrence of 3 beta,12 alpha-dihydroxy-5-cholenoic acid associated with 3 beta-hydroxy-5-cholenoic acid and their preferential urinary excretion in liver diseases. Shoda J, Osuga T, Matsuura K, Mahara R, Tohma M, Tanaka N, Matsuzaki Y, Miyazaki H. J Lipid Res; 1989 Aug 15; 30(8):1233-42. PubMed ID: 2769075 [Abstract] [Full Text] [Related]
15. Cholestenoic acids regulate motor neuron survival via liver X receptors. Theofilopoulos S, Griffiths WJ, Crick PJ, Yang S, Meljon A, Ogundare M, Kitambi SS, Lockhart A, Tuschl K, Clayton PT, Morris AA, Martinez A, Reddy MA, Martinuzzi A, Bassi MT, Honda A, Mizuochi T, Kimura A, Nittono H, De Michele G, Carbone R, Criscuolo C, Yau JL, Seckl JR, Schüle R, Schöls L, Sailer AW, Kuhle J, Fraidakis MJ, Gustafsson JÅ, Steffensen KR, Björkhem I, Ernfors P, Sjövall J, Arenas E, Wang Y. J Clin Invest; 2014 Nov 15; 124(11):4829-42. PubMed ID: 25271621 [Abstract] [Full Text] [Related]
16. [Clinical features of a Chinese infant with inborn error of bile acid metabolism-3β-hydroxy-Δ(5)-C27-steroid dehydrogenase deficiency and review of the literature]. Yang TJ, Xie XB, Yao WL, Wang HJ, Yu H, Wang XH. Zhonghua Er Ke Za Zhi; 2013 Aug 15; 51(8):625-9. PubMed ID: 24225297 [Abstract] [Full Text] [Related]
17. Alterations of bile acid composition in gallstones, bile, and liver of patients with hepatolithiasis, and their etiological significance. Shoda J, Tanaka N, He BF, Matsuzaki Y, Osuga T, Miyazaki H. Dig Dis Sci; 1993 Nov 15; 38(11):2130-41. PubMed ID: 8223090 [Abstract] [Full Text] [Related]
18. Ethanol has an acute effect on bile acid biosynthesis in man. Axelson M, Mörk B, Sjövall J. FEBS Lett; 1991 Apr 09; 281(1-2):155-9. PubMed ID: 2015886 [Abstract] [Full Text] [Related]
19. Serum concentrations of 7alpha-hydroxy-4-cholesten-3-one reflect bile acid synthesis in humans. Sauter G, Berr F, Beuers U, Fischer S, Paumgartner G. Hepatology; 1996 Jul 09; 24(1):123-6. PubMed ID: 8707250 [Abstract] [Full Text] [Related]
20. Sequential changes in serum levels of individual bile acids in patients with chronic cholestatic liver disease. Azer SA, Coverdale SA, Byth K, Farrell GC, Stacey NH. J Gastroenterol Hepatol; 1996 Mar 09; 11(3):208-15. PubMed ID: 8742915 [Abstract] [Full Text] [Related] Page: [Next] [New Search]